MHRA regulatory news highlights November 2025

5 December 2025

From the regulatory newsfeed of the Medicines and Healthcare products Regulatory Agency (MHRA), Arex Advisor has rounded up a selection of highlights from November 2025.

Expert highlights key principles for regulating AI in healthcare

19 November 2025
Professor Alastair Denniston sets out core principles to guide how artificial intelligence should be regulated as it becomes increasingly embedded in clinical practice. His perspective underscores the need for clear, reliable, and patient-centred oversight to ensure safe and effective use of AI-driven technologies in healthcare. Read more

MHRA offers tailored regulatory advice for medical and IVD devices

3 December 2025
The MHRA has outlined how developers can request regulatory advice meetings for medical devices and in vitro diagnostics, particularly where existing guidance is difficult to apply. The service helps organisations clarify regulatory expectations early, supporting smoother development and assessment of innovative technologies. Read more

How do these changes affect you?

Our experienced specialists are ready to help you navigate the regulatory landscape!

Staffan Thunell

Founding partner

BSc Economics and BA

Staffan has a long background in entrepreneurship within the life science industry. He has 20+ years experience from posit­ions as Founder, Chair­man, CEO and CFO within medical affairs consulting and small pharma. Previously Staffan worked in executive positions in big pharma and specialty pharma companies.